Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,022
Total Claims
$746K
Drug Cost
485
Beneficiaries
$1,539
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-96%
Opioid rate vs peers
0.1% vs 2.5% avg
+36%
Cost per patient vs peers
$1,539 vs $1,128 avg
+42%
Brand preference vs peers
11.9% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
21
Opioid Claims
$179
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,215 claims · $582K
Generic: 16,346 claims · $153K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 181 | $72K |
| Insulin Lispro | 99 | $47K |
| Insulin Nph Hum/Reg Insulin Hm | 128 | $42K |
| Apixaban | 72 | $42K |
| Rivaroxaban | 66 | $34K |
| Sitagliptin Phosphate | 49 | $32K |
| Oxcarbazepine | 12 | $27K |
| Linagliptin | 34 | $21K |
| Levetiracetam | 12 | $21K |
| Levothyroxine Sodium | 353 | $19K |
| Ticagrelor | 41 | $17K |
| Silver Sulfadiazine | 286 | $14K |
| Lacosamide | 12 | $14K |
| Dapagliflozin Propanediol | 20 | $13K |
| Sitagliptin Phos/Metformin Hcl | 18 | $11K |
Prescribing Profile
Patient Profile
81
Avg Age
64%
Female
2.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data